FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an injection solution for treating viral diseases specified in H1N1, H3N2, H5N1 influenza, tick-borne encephalitis and West Nile fever, containing triazavirin in an amount of 0.05-4.0 wt %, additives in an amount of 0.1-30.0 wt % and water up to 100 wt %.
EFFECT: invention provides high metabolic stability and accessibility with maximum efficacy in antiviral action on virus replication.
4 cl, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
INJECTION OR INFUSION SOLUTION OF L-ARGININE SALT OF 5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-a] PYRIMIDIN-7-ONE MONOHYDRATE FOR THERAPY OF INFLUENZA AND OTHER VIRAL INFECTIONS | 2014 |
|
RU2586283C1 |
CONJUGATES OF 2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4I')-ONE WITH GLUTADIONE AND OTHER PEPTIDES, POSSESSING ANTIVIRAL ACTIVITY | 2012 |
|
RU2516936C2 |
5-METHYL-6-NITRO-7-OXO-4,7-DIHYDRO-1,2,4-TRIAZOLO[1,5-ALPHA]PYRIMIDINIDE L-ARGININIUM MONOHYDRATE | 2013 |
|
RU2529487C1 |
SODIUM SALT OF 2-METHYLTHIO-6-CYANO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZIN-7(4H)-ONE, TRIHYDRATE | 2015 |
|
RU2607628C1 |
SODIUM SALT OF 2-METHYL-6-FLUORO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4H)-ONE DIHYDRATE, HAVING ANTIVIRAL ACTIVITY | 2009 |
|
RU2493158C2 |
2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZINE-7(4H)-ONE SODIUM SALT DIHYDRATE POSSESSING ANTIVIRAL ACTIVITY | 2005 |
|
RU2294936C1 |
6-(2'-AMINO-2'-CARBOXYETHYLTHIO)-2-METHYLTHIO-4-PIVALOYLOXY-METHYL-1,2,4-TRIAZOLO[5,1-c] 1,2,4-TRIAZIN-7(4H)-ONE | 2011 |
|
RU2455304C1 |
3-NITRO-4-HYDROXY-7-PROPARGYLTHIO-[1,2,4]TRIAZOLO[5,1c][1,2,4]TRIAZINE AND 3-NITRO-4-HYDROXY-7-ETHYLTHIO-[1,2,4]TRIAZOLO[5,1c][1,2,4]TRIAZINE WITH ANTIVIRAL ACTIVITY | 2019 |
|
RU2775551C2 |
AZOLOAZINE SALTS OF FLUOROQUINOLONES, POSSESSING ANTIBACTERIAL AND ANTIVIRAL ACTION | 2014 |
|
RU2547835C1 |
SODIUM SALT OF 2-ETHYLTHIO-6-NITRO-1,2,4-TRIAZOLE[5,1-c]-1,2,4-TRIAZIN-7-ONE DIHYDRATE | 2008 |
|
RU2404182C2 |
Authors
Dates
2016-01-27—Published
2013-10-16—Filed